Some GLP-1 users are getting scurvy

Some patients taking popular weight-loss drugs are ending up with a condition associated with 18th-century sea voyages: scurvy. GLP-1 medications such as Ozempic suppress appetite so effectively that some users are consuming too little nutrient-dense food, researchers say, putting them at risk for vitamin deficiencies, which can affect bone, brain,...